Ascentage Pharma Group Internat AAPG
13.48 USD -0.08 (-0.59%)
At closeNov 3, 2026, 4:00 PM EST
13.63 +0.15 +1.11%
After hours · Nov 3, 4:00 PM ET
13.48 Day range 13.78
13.46 52-week range 34.50
- YTD
- -48.63%
- 1 year
- -60.70%
News
globenewswire.com Ascentage Pharma to Participate in Two Upcoming Investor Conferences in London ROCKVILLE, Md., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated…
globenewswire.com Ascentage Pharma's Lisaftoclax Granted Breakthrough Therapy Designation in China for Treatment-Naïve CLL/SLL ROCKVILLE, Md., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company engaged in the…
benzinga.com Ascentage Pharma Stock Could More Than Double: Analyst Ascentage Pharma Group International (NASDAQ:AAPG) stock could see significant upside as the cancer drug developer approaches several major clinical trial results in 2027, according to William Blair.
benzinga.com Ascentage Pharma Stock Could More Than Double: Analyst William Blair sees major upside for Ascentage Pharma stock as the cancer drug developer approaches three pivotal trial results in 2027.
benzinga.com William Blair Initiates Coverage On Ascentage Pharma Group with Outperform Rating William Blair analyst Alethia Young initiates coverage on Ascentage Pharma Group (NASDAQ:AAPG) with a Outperform rating.
benzinga.com Citigroup Initiates Coverage On Ascentage Pharma Group with Buy Rating, Announces Price Target of $46 Citigroup analyst Yigal Nochomovitz initiates coverage on Ascentage Pharma Group (NASDAQ:AAPG) with a Buy rating and announces Price Target of $46.
benzinga.com Citizens Initiates Coverage On Ascentage Pharma Group with Market Outperform Rating, Announces Price Target of $35 Citizens analyst Silvan Turkcan initiates coverage on Ascentage Pharma Group (NASDAQ:AAPG) with a Market Outperform rating and announces Price Target of $35.
defenseworld.net Ascentage Pharma Group International (NASDAQ:AAPG) Shares Up 4% – Should You Buy? Ascentage Pharma Group International - Unsponsored ADR (NASDAQ: AAPG - Get Free Report) traded up 4% during trading on Monday. The stock traded as high as $15.19 and last traded at $15.3390.…
marketbeat.com 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead Small-cap stocks tend to fly under the radar. Often in startup stages, these companies can lack analyst coverage, be overlooked by institutional investors, and be illiquid due to low average trading…
benzinga.com JP Morgan Maintains Overweight on Ascentage Pharma Group, Lowers Price Target to $33 JP Morgan analyst Brian Cheng maintains Ascentage Pharma Group (NASDAQ:AAPG) with a Overweight and lowers the price target from $46 to $33.
benzinga.com Constellation Brands, Caribou Biosciences And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session U.S. stock futures fell; Constellation Brands dropped 5.1% despite beating estimates, while biotech, mining and other stocks declined premarket.
marketbeat.com 3 Small-Cap Stocks With Catalysts That Could Put Them in the Spotlight Small-cap companies are accustomed to living in the shadow of mega-cap tech firms, but there are signs that the market backdrop could be changing for some of these companies. Investors have been…
benzinga.com Align Technology, Group 1 Automotive And Other Big Stocks Moving Lower In Monday’s Pre-Market Session U.S. stock futures fell as HubSpot dropped after a downgrade; Roze AI, UMC, Quantum-Si, Intel and others also declined premarket.
benzinga.com Nike Posts Mixed Q1 Results, Joins Mangoceuticals And Other Big Stocks Moving Lower In Friday’s Pre-Market Session U.S. stock futures rose, while Nike plunged 9.5% after missing revenue estimates. Roze AI, Mangoceuticals and other stocks also fell premarket.
defenseworld.net Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) Receives Average Recommendation of “Buy” from Brokerages Shares of Ascentage Pharma Group International - Unsponsored ADR (NASDAQ: AAPG - Get Free Report) have been assigned a consensus rating of "Buy" from the ten brokerages that are presently covering…
defenseworld.net Ascentage Pharma Group International (NASDAQ:AAPG) Sets New 12-Month Low – Time to Sell? Ascentage Pharma Group International - Unsponsored ADR (NASDAQ: AAPG - Get Free Report)'s share price reached a new 52-week low during mid-day trading on Thursday. The company traded as low as $15.40…
globenewswire.com Ascentage Pharma to Participate in Four Upcoming Investor Conferences ROCKVILLE, Md., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated…
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session Gainers VolitionRX (AMEX:VNRX) shares increased by 102.2% to $0.69 during Thursday's pre-market session. The company's market cap stands at $4.8 million. NewcelX (NASDAQ:NCEL) shares increased by…
seekingalpha.com Ascentage Pharma Group International (AAPG) Q2 2026 Earnings Call Transcript Ascentage Pharma Group International (AAPG) Q2 2026 Earnings Call Transcript
marketbeat.com Ascentage Pharma Group International H1 Earnings Call Highlights Ascentage Pharma Group International NASDAQ: AAPG reported first-half 2026 revenue growth as it continued investing in global registrational studies for its hematology-oncology pipeline and began…
globenewswire.com Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates Revenue for the first half of 2026 increased 29% year-over-year to US$44.5 million (RMB302.2 million), primarily attributable to increased product sales. Expanded executive leadership with…
globenewswire.com Ascentage Pharma to Participate in the Evercore 2nd Annual China Biotech Summit ROCKVILLE, Md., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated…
defenseworld.net Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up – Still a Buy? Shares of Ascentage Pharma Group International - Unsponsored ADR (NASDAQ: AAPG - Get Free Report) gapped up prior to trading on Friday. The stock had previously closed at $16.85, but opened at…
globenewswire.com CORRECTION: Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026 In a release issued under the same headline earlier today by Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), please note that in the first paragraph of the release, the time should…
globenewswire.com Ascentage Pharma to Report 2026 Six Month Interim Results and Provide Corporate Update on August 19, 2026 ROCKVILLE, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company”), a global, commercial-stage, integrated…
globenewswire.com Ascentage Pharma Appoints Dr. Faiçal Miyara as Chief Business Officer and Jim Ziegler as Chief Commercial Officer ROCKVILLE, Md., Aug. 02, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company engaged in the…
zacks.com Wall Street Analysts Predict a 160.09% Upside in Ascentage Pharma Group International - Unsponsored ADR (AAPG): Here's What You Should Know The average of price targets set by Wall Street analysts indicates a potential upside of 160.1% in Ascentage Pharma Group International - Unsponsored ADR (AAPG). While the effectiveness of this…
globenewswire.com Ascentage Pharma Chairman and CEO Dr. Dajun Yang Named to The Medicine Maker Power List 2026 ROCKVILLE, Md. and SUZHOU, China, July 26, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company…
zacks.com How Much Upside is Left in Ascentage Pharma Group International - Unsponsored ADR (AAPG)? Wall Street Analysts Think 152.23% The consensus price target hints at a 152.2% upside potential for Ascentage Pharma Group International - Unsponsored ADR (AAPG). While empirical research shows that this sought-after metric is hardly…
benzinga.com ON Semiconductor, SanDisk And Other Big Stocks Moving Lower In Friday’s Pre-Market Session U.S. stock futures down, Nasdaq 100 futures drop over 1%. ON Semi to acquire Synaptics, ON shares fall 13%. Other stocks also down in pre-market.
benzinga.com Applied Digital, Simply Good Foods And Other Big Stocks Moving Lower In Thursday's Pre-Market Session U.S. stock futures lower on Thursday with Applied Digital Corp. (APLD) falling sharply in pre-market trading after beating analyst estimates.
benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
benzinga.com Why nCino Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket Shares of nCino Inc (NASDAQ: NCNO) jumped 18% in pre-market trading after reporting strong Q4 results and issuing positive guidance for Q1 and FY27.
benzinga.com Earnings Scheduled For March 25, 2026 
benzinga.com Monte Rosa Therapeutics, Ventyx Biosciences, United Microelectronics And Other Big Stocks Moving Higher On Wednesday 
benzinga.com Novo Nordisk, Sable Offshore, StoneCo And Other Big Stocks Moving Higher On Tuesday 
benzinga.com Cementos Pacasmayo, Rezolve AI, Emerald Holding And Other Big Stocks Moving Higher On Monday 
benzinga.com This Hasbro Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday 
benzinga.com This Docebo Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday 
benzinga.com Keurig Dr Pepper, Valneva, Venu Holding And Other Big Stocks Moving Lower On Monday 
benzinga.com Earnings Scheduled For August 20, 2025 
benzinga.com US Stocks Likely To Open Mixed As Trump Issues Tariff Letters: Experts Peg AI Investments As 'Durable Drivers Of Returns' U.S. stock futures were fluctuating on Tuesday after trimming gains on Monday. Futures of major benchmark indices were trading mixed.
benzinga.com Penguin Solutions, Merit Medical Systems And 3 Stocks To Watch Heading Into Tuesday 
benzinga.com PDD Holdings Posts Weak Results, Joins EHang Holdings And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session 
benzinga.com Bitdeer Tech And Tempus AI Are Among Top 18 Mid-Cap Gainers Last Week (Apr 21-Apr 25): Are The Others In Your Portfolio? Top mid-cap stock performers last week: Ascentage Pharma, Ardagh Metal, Bitdeer Tech, Pegasystems, Impinj, Lufax, Tempus AI, Kymera Therapeutics.
benzinga.com Earnings Scheduled For March 27, 2025